Free Design Audit Available - Click Here for Details

MedTech News

FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test

SILVER SPRING, Md., June 27, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert Xpress System, the first hepatitis C virus (HCV) test that can be used to bring diagnosis to appropriately certified point-of-care settings for individuals at risk for hepatitis C.

Read More »

Sign up for Blog Updates